HCA Stock Analysis
NYQ · Healthcare · Medical Care Facilities
$435.13
-0.48 (-0.11%)
HCA Interactive Price Chart & Trading Signals
HCA Stock Snapshot — Valuation, Risk & Technical Signals
HCA Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$94.21B
P/E Ratio
14.58
Forward P/E
13.59
PEG Ratio
1.33
P/B Ratio
-14.28
EPS
$29.84
Dividend Yield
0.72%
52W Range
$353.99 – $556.52
Beta
1.11
Volume
0.3M
ROE
—
Profit Margin
8.8%
Revenue Growth
8.7%
Gross Margin
42.6%
EV/EBITDA
9.41
Analyst Target
$454.23
The trailing price-to-earnings ratio stands at 14.6x. Forward P/E of 13.6x implies earnings expansion expected. EV/EBITDA sits at 9.41x. Market capitalization is $94.21B. Revenue is growing at 8.7% on a trailing basis. Earnings are expanding at 11.6%. Profit margins are 8.8%. Beta of 1.11 indicates market-average volatility.
Analyst Consensus
Recommendation
Buy
Low Target
$380.00
Mean Target
$454.23
High Target
$579.00
Based on 22 analysts
About HCA
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Deep Dive Analysis
Bottom Line
Verdict
UndervaluedBest for
Value-oriented investorsWatch out for
None flaggedNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
HCA Healthcare, Inc. (HCA) trades below our multi-model fair value estimate of $538.29 by approximately 23.7%. Trailing P/E: 14.6x. Profitability signals include profit margin of 8.8%. Recent growth metrics show revenue growth of 8.7% and earnings growth of 11.6%. Risk profile: beta of 1.11. Consensus: buy.
Valuation, Growth & Risk
Valuation
Undervalued
P/E 14.6x
Price sits below our estimate of fair value.
Growth
Expanding
Rev 8.7%
Revenue is outpacing the market.
Valuation Snapshot
HCA Healthcare, Inc. (HCA) trades below our multi-model fair value estimate of $538.29 by approximately 23.7%. The trailing price-to-earnings ratio stands at 14.6x. Forward P/E of 13.6x indicates stable forward expectations. Price-to-sales is 1.2x. EV/EBITDA sits at 9.4x. Market capitalization is $94.21B.
Why it matters: Buying below fair value can create a margin of safety, but always check earnings quality.
Growth & Profitability
Revenue is growing at 8.7% on a trailing basis. Earnings are expanding at 11.6%. Profit margins are 8.8%. Return on assets is 12.3%.
Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.
Risk Profile
Beta of 1.11 indicates market-average volatility. Net debt position is $50.42B.
Why it matters: Lower risk means steadier returns, but often with less upside in bull markets.
Analyst Context
Analyst consensus target of $454.23 implies 4.4% upside. Target range spans $380.00 to $579.00. 22 analysts cover the stock. Consensus recommendation: buy.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Investor Fit
The combination of undervaluation and moderate risk may suit value-oriented investors. Free cash flow yield of 8.2% is attractive for cash-flow-focused investors.
Takeaway: Match the stock's risk-reward profile with your own goals and time horizon. No single metric tells the whole story.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
HCA Undervalued
HCA Healthcare, Inc. (HCA) trades below our multi-model fair value estimate of $538.29 by approximately 23.7%.
Frequently Asked Questions
ValuationIs HCA stock overvalued right now?
ValuationWhat is HCA fair value based on current fundamentals?
RiskHow risky is HCA compared with other stocks?
GrowthIs HCA still growing?
AnalystWhat do analysts think about HCA?
DividendDoes HCA pay a dividend?
CatalystWhat could change the investment case for HCA?
Related Stocks
About the Author
Phasakorn Traklang (Peach) — Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.